Continuous Infusion of Vecuronium
- 1 October 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 67 (4) , 503-506
- https://doi.org/10.1097/00000542-198710000-00010
Abstract
The authors studied the effects of enflurane, isoflurane, and fentanyl, each in combination with 60% nitrous oxide, on the vecuronium infusion rate necessary to maintain constant 90% depression of control muscle twitch tension. Thirty healthy surgical patients were given an initial 0.1 mg/kg bolus of vecuronium, followed by an infusion of vecuronium at an initial rate of 1.0 .mu.g .cntdot. kg-1 .cntdot. min-1. After 1 h of steady-state 90% twitch depression, plasma vecuronium concentrations (Css90) were measured by capillary column gas chromatography. Total plasma clearance of vecuronium was estimated using Css90 values. Vecuronium infusion rates (mean .+-. SD) were similar for patients given enflurane (0.28 .+-. 0.13 .mu.g .cntdot. kg-1 .cntdot. min-1) and isoflurane (0.30 .+-. 0.13 .mu.g .cntdot. kg-1 .cntdot. min-1), but significantly higher in patients given fentanyl (0.92 .+-. 0.37 .mu.g .cntdot. kg-1 .cntdot. min-1). Values for Css90 in the patients receiving enflurane and isoflurane were similar (71 .+-. 34 and 72 .+-. 44 ng/ml, respectively), but significantly higher in those receiving fentanyl (165 .+-. 48 ng/ml). Total plasma clearance was similar during enflurane, isoflurane, and fentanyl anesthesia (4.4 .+-. 2.6, 4.6 .+-. 1.2, and 5.6 .+-. 1.9 ml .cntdot. kg-1, respectively). The authors conclude that patients receiving isoflurane and enflurane require markedly lower vecuronium infusion rates to achieve 90% neuromuscular blockade than those receiving fentanyl. The enhancement of neuromuscular blockade by isoflurane and enflurane represents a change in the pharmacodynamics of vecuronium-induced neuromuscular blockade, rather than a change in pharmacokinetics.This publication has 10 references indexed in Scilit:
- HEPATOBILIARY DISPOSITION OF VECURONIUM BROMIDE IN MANBritish Journal of Anaesthesia, 1986
- Vecuronium Infusion Dose Requirements during Fentanyl and Halothane Anesthesia in HumansAnesthesia & Analgesia, 1985
- Vecuronium-induced Neuromuscular Blockade during Enflurane, Isoflurane, and Halothane Anesthesia in HumansAnesthesiology, 1984
- Pharmacokinetics and Pharmacodynamics of Vecuronium (ORG NC45) and Pancuronium in Anesthetized HumansAnesthesiology, 1983
- PHARMACOKINETICS OF ORG NC45 (NORCURON) IN PATIENTS WITH AND WITHOUT RENAL FAILUREBritish Journal of Anaesthesia, 1981
- Clinical Pharmacology of ORG NC45 (NorcuronTM)Anesthesiology, 1981
- The Emergence of ORG NC 45, 1- [(2β,3α, 5α,16β, 17β)-3, 17-BIS(Acetyloxy)-2-(1-Piperidinyl)-Androstan-16-YL]-1-Methylpiperidinium Bromide, from the Pancuronium SeriesBritish Journal of Anaesthesia, 1980
- Time-dependent Increase in Sensitivity to d-Tubocurarine during Enflurane Anesthesia in ManAnesthesiology, 1980
- Pharmacokinetics and Pharmacodynamics of d-Tubocurarine during Nitrous Oxide–Narcotic and Halothane Anesthesia in ManAnesthesiology, 1979
- Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarineClinical Pharmacology & Therapeutics, 1979